DagmarHedrich EMCDDA In programme October 23 13:20 to 14:50 October 23 15:00 to 16:30 October 23 15:35 to 15:55 October 23 17:00 to 17:15 October 24 15:00 to 16:30 October 24 16:10 to 16:25 View hours & dates Hours & Dates Plenary session Poster session Big debate Structured session Workshop Oral presentation session Short communication session Poster guided tour 13:20 The future of hepatitis C among people who inject drugs 13:20 to 14:50Main stageDagmar HedrichErika Duffell 15:00 Practical tools developed under the EMCDDA ‘Harm reduction initiative’ Enhancing the role of drug treatment services for HCV elimination among people who inject drugs 15:00 to 16:30Central square 1 (C1)Dagmar HedrichMatthew Hickman Take-home naloxone — its role in preventing opioid-related deaths in Europe 15:00 to 16:30Insights zone 3 (I3)Dagmar HedrichSir John Strang 15:35 Oral presentation How HCV testing and care can be delivered through drug services: Evidence-base, case studies and 'real life' implementation experiences 15:35 to 15:55 Central square 1 (C1) Dagmar HedrichEberhard Schatz 17:00 Oral presentation Introduction and short presentation on harm reduction monitoring 17:00 to 17:15 Insights zone 1 (I1) Dagmar Hedrich 16:10 Oral presentation Reducing drug-related deaths in Europe: a systemic perspective with focus on take-home naloxone 16:10 to 16:25 Insights zone 3 (I3) Dagmar Hedrich